Explore News By Topic
06/19/2017
New three-in-one blood test opens door to precision medicine for prostate cancer
Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance LONDON, June 18, 2017 - Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate... Read More
06/03/2017
Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival
ASCO Perspective “For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone,” said Sumanta Kumar Pal, MD, ASCO Expert. “This is good news because using abiraterone could help many people live longer with fairly few additional side... Read More
06/01/2017
Prostate Cancer Foundation and Major League Baseball Launch Annual Home Run Challenge to Defeat Prostate Cancer
LOS ANGELES, June 1, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are launching the annual Home Run Challenge on June 1, and running through Father's Day, June 18, in all 30 MLB ballparks throughout the United States and Canada. For the first time, all MLB... Read More
05/17/2017
Many vs Cancer, the First Major Global Crowdfunding Initiative to Defeat Prostate Cancer, Launches Today
LOS ANGELES, May 17, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the launch of Many vs Cancer (MvC), its first global fundraising initiative that is harnessing the collective power of those touched by prostate cancer with the scientists working to defeat it. MvC aims to empower patients,... Read More
05/17/2017
Study finds genetic difference in prostate cancer in African-Americans
Dana-Farber Cancer Institute News Release May 17,2017 The genomic discovery may partly explain why prostate cancer is more aggressive in black men Scientists say more blacks and other under-represented groups should be included in genomic studies to enable precision medicine BOSTON –– A new genomic study has identified prostate cancer... Read More
05/11/2017
Scientists Identify Biomarkers to Guide Hormone Therapy for Prostate Cancer
University of California San Francisco News Release May 11, 2017 A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy, according to a study led by scientists at UC San Francisco and the University of Michigan.... Read More
05/08/2017
Advanced Prostate Cancer Treatment Failure Due to Cell Reprogramming
New York, NY (May 4, 2017)—Columbia University Medical Center (CUMC) researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy. The findings, based on a study in mice, could help to determine which patients should avoid anti-androgen therapy... Read More
02/14/2017
Prostate Cancer Foundation Announces New Recipients of 2016 PCF Challenge Awards to Promote Research in Deadly Prostate Cancer
SANTA MONICA, CA Feb. 14, 2017 – The Prostate Cancer Foundation (PCF) today announced that it has granted eight new 2016 PCF Challenge Awards to advance treatments and cures for metastatic or currently incurable prostate cancer. PCF Challenge Awards are multi-year awards supporting cross-disciplinary teams of research scientists. In 2016,... Read More
08/02/2016
2016 Movember Foundation – PCF Challenge Awards Fund Advances in Precision Treatment
Prostate Cancer Foundation Receives More Than $5 Million from the Movember Foundation 5 New Challenge Awards will Fund Investigations in Lethal Prostate Cancer SANTA MONICA, CA August 2, 2016 -- The Prostate Cancer Foundation (PCF) announces 5 new Movember Foundation-PCF Challenge Awards to advance new treatments and cures for metastatic,... Read More
06/23/2016
PROSTATE CANCER FOUNDATION ANNOUNCES 24 NEW YOUNG INVESTIGATOR AWARDS
SANTA MONICA, CA June 23, 2016 – The Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) Awards to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the Class of 2016 were selected from a pool of 128 applicants from 77... Read More